Biomedical Engineering Reference
In-Depth Information
[58] DeNardo SJ, DeNardo gL, miers LA, Natarajan A, foreman AR, gruettner C, Adamson
gN, Ivkov R. Development of tumor targeting bioprobes (111In-chimeric L6 mono-
clonal antibody nanoparticles) for alternating magnetic field cancer therapy. Clin Cancer
Res 2005;
11
:7087s-7092s.
[59] DeNardo SJ, DeNardo gL, Natarajan A, miers LA, foreman AR, gruettner C, Adamson
gN, Ivkov R. Thermal dosimetry predictive of efficacy of 111In-ChL6 nanoparticle
Amf-induced thermoablative therapy for human breast cancer in mice. J Nucl med
2007;
48
:437-444.
[60] Natarajan A, gruettner C, Ivkov R, DeNardo gL, mirick g, Yuan A, foreman A,
DeNardo SJ. Nanoferrite particle based radioimmunonanoparticles: binding affinity and
in vivo
pharmacokinetics. bioconjug Chem 2008;
19
:1211-1218.
[61] madru R, Kjellman p, Olsson f, Wingårdh K, Ingvar C, Ståhlberg f, Olsrud J, Lätt J,
fredriksson S, Knutsson L, Strand S-e. 99mTc-labeled superparamagnetic iron oxide
nanoparticles for multimodality SpeCT/mRI of sentinel lymph nodes. J Nucl med
2012;
53
:459-463.
[62] Torres martin de Rosales R, Tavaré R, glaria A, Varma g, protti A, blower pJ.
99mTc-bisphosphonate-iron oxide nanoparticle conjugates for dual-modality bio-
medical imaging. bioconjug Chem 2011;
22
:455-465.
[63] Lalatonne Y, paris C, Serfaty Jm, Weinmann p, Lecouvey m, motte L. bis-phosphonates-
ultra small superparamagnetic iron oxide nanoparticles: a platform towards diagnosis
and therapy. Chem Commun (Camb) 2008:2553-2555.
[64] Lalatonne Y, monteil m, Jouni H, Serfaty Jm, Sainte-Catherine O, Lièvre N, Kusmia S,
Weinmann p, Lecouvey m, motte L. Superparamagnetic bifunctional bisphosphonates
nanoparticles: a potential mRI contrast agent for osteoporosis therapy and diagnostic.
J Osteoporosis 2010;
2010
:747852.
[65] benyettou f, Lalatonne Y, Sainte-Catherine O, monteil m, motte L. Superparamagnetic
nanovector with anti-cancer properties: γfe2O3@Zoledronate. Int J pharm 2009;
379
:
324-327.
[66] Tomalia DA, Reyna LA, Svenson S. Dendrimers as multi-purpose nanodevices for
oncology drug delivery and diagnostic imaging. biochem Soc Trans 2007;
35
:61-67.
[67] Zhang Y, Sun Y, Xu X, Zhu H, Huang L, Zhang X, Qi Y, Shen Y-m. Radiosynthesis and
micro-SpeCT imaging of 99mTc-dendrimer poly(amido)-amine folic acid conjugate.
bioorg med Chem Lett 2010;
20
:927-931.
[68] Xu X, Zhang Y, Wang X, guo X, Zhang X, Qi Y, Shen Y-m. Radiosynthesis, biodistribu-
tion and micro-SpeCT imaging study of dendrimer-avidin conjugate. bioorg med Chem
2011;
19
:1643-1648.
[69] Zhang Y, Sun Y, Xu X, Zhang X, Zhu H, Huang L, Qi Y, Shen Y-m. Synthesis, biodistri-
bution, and microsingle photon emission computed tomography (SpeCT) imaging study
of technetium-99m labeled pegylated dendrimer poly(amidoamine) (pAmAm)−folic
acid conjugates. J med Chem 2010;
53
:3262-3272.
[70] Utreja p, Jain S, Tiwary AK. Novel drug delivery systems for sustained and targeted
delivery of anti-cancer drugs: current status and future prospects. Curr Drug Deliv
2010;
7
:152-161.
[71] Sahoo Ng, bao H, pan Y, pal m, Kakran m, Cheng HKf, Li L, Tan Lp. functionalized
carbon nanomaterials as nanocarriers for loading and delivery of a poorly water-soluble
anticancer drug: a comparative study. Chem Commun (Camb) 2011;
47
:5235-5237.
Search WWH ::
Custom Search